Who owns Maze Therapeutics Inc (MAZE)? Superinvestor holders
3 superinvestors of the 157 tracked here hold Maze Therapeutics Inc (MAZE) in their latest 13F filing, with $42.3M between them. Zhang Lei gives it the most weight: 1.31% of the reported portfolio. In their latest reported quarter, Harvard endowment opened a position.
Key facts
- Superinvestors holding it
- 3 of 157
- Biggest holder
- Andrew Spokes, $30.1M
- Largest weight
- Zhang Lei, 1.31%of their portfolio
- Combined value
- $42.3M
- Bought last quarter
- 1
- Sold last quarter
- 0
From each investor's latest 13F filing: 92 investors report Q3 2026, 65 investors report Q2 2026. Latest filing in this set: Nov 16, 2026.
| # | Investor | Share of their portfolio | Value | Shares | Last quarter | Shares moved | Quarter |
|---|---|---|---|---|---|---|---|
| 1 | Zhang LeiHHLR Advisors (Hillhouse) | 1.31% | $10.9M | 366.03K | No change | 0 | Q2 2026 |
| 2 | Andrew SpokesFarallon Capital Management | 0.16% | $30.1M | 1.11M | No change | 0 | Q3 2026 |
| 3 | Harvard endowmentHarvard Management Company | 0.03% | $1.3M | 48.21K | New | +48.21K | Q3 2026 |
Quarter by quarter
| Quarter | Filings in | Holders | Combined shares | Combined value | Bought | Sold |
|---|---|---|---|---|---|---|
| Q3 2026 | 92 | 2 | 1.16M | $31.4M | 1 | 0 |
| Q2 2026 | 157 | 2 | 1.47M | $44M | 1 | 0 |
| Q1 2026 | 157 | 2 | 739.03K | $22.1M | 1 | 1 |
| Q4 2025 | 157 | 1 | 457.54K | $19M | 0 | 1 |
| Q3 2025 | 157 | 2 | 549.93K | $14.3M | 0 | 1 |
| Q2 2025 | 157 | 2 | 1.1M | $13.4M | 0 | 0 |
| Q1 2025 | 156 | 2 | 1.1M | $12.1M | 2 | 0 |
| Q4 2024 | 156 | 0 | — | — | 0 | 0 |
A quarter's holder count is out of the filings in for that quarter — the newest quarter fills up over the 45 days investors have to file.
Each holder's shares
| Investor | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|---|---|
| Andrew Spokes | 1.11M | 1.11M | 373K | — | — | — | — | — |
| Harvard endowment | 48.21K | — | — | — | 92.4K | 637.53K | 637.53K | — |
| Zhang Lei | · | 366.03K | 366.03K | 457.54K | 457.54K | 457.54K | 457.54K | — |
A dash: the investor filed for that quarter without this stock among their largest positions. A dot: no filing of theirs for that quarter is on file.
Questions and answers
Which superinvestors own MAZE?
In their latest 13F filings: Zhang Lei (1.31% of the portfolio, $10.9M), Andrew Spokes (0.16% of the portfolio, $30.1M), Harvard endowment (0.03% of the portfolio, $1.3M).
Who bought MAZE last quarter?
Harvard endowment (new position). “Last quarter” is each investor's latest reported quarter.
How current is this?
It comes from Form 13F, which large managers file within 45 days of each quarter's end; the latest filing read here was made on Nov 16, 2026. Positions may have changed since, and a 13F shows long US-listed positions only.
Learn
Cite this page
Funkfolio, “Who owns Maze Therapeutics Inc (MAZE)? Superinvestor holders”, data as of 16 November 2026. https://funkfolio.com/stock/MAZE/superinvestors
Underlying data: SEC EDGAR, Form 13F-HR filings of the investors tracked here.
Source: SEC EDGAR, Form 13F-HR filings of the 157 investors tracked here, matched to MAZE by security number and name. Only each investor's 150 largest positions per filing are read, so a small line in a very long portfolio is not seen, and a security held without a matched ticker cannot be found. “Last quarter” compares share counts with the investor's previous filing. Share counts are restated for a split only where a tracked investor held the stock through it. Filings appear up to 45 days after a quarter ends and show long US-listed positions only; this is not advice.